Loading...
MISX
APTK
Market cap470mUSD
Jul 14, Last price  
4.81RUB
1D
-3.57%
1Q
-37.62%
Jan 2017
-53.33%
IPO
-98.37%
Name

Aptechnaya Set' 36,6 PAO

Chart & performance

D1W1MN
MISX:APTK chart
P/E
139.61
P/S
0.35
EPS
0.03
Div yield, %
—
Shrs. gr., 5y
1.98%
Rev. gr., 5y
21.88%
Revenues
105.61b
+21.17%
14,371,464,89220,765,084,45930,718,248,44821,061,500,00020,381,100,00021,594,000,00020,923,000,00011,911,000,00019,071,000,00031,890,000,00045,947,000,00048,253,000,00044,664,000,00046,049,000,00039,267,000,00044,104,000,00059,048,000,00067,358,000,00087,163,000,000105,614,000,000
Net income
263m
-1.50%
937,431,30900-359,400,000-929,600,000-1,034,000,000-971,000,000-10,400,000,000-115,000,000-178,000,000-9,345,000,000-13,097,000,000-22,977,000,000-8,855,000,0006,351,000,000-950,000,000223,000,000120,000,000267,000,000263,000,000
CFO
5.07b
-21.92%
-1,189,193,7610378,612,362-2,377,000,000-1,929,000,000-1,000,000809,000,000-3,628,000,000-356,000,0003,806,000,000-3,483,000,000-11,134,000,000-9,196,000,000-1,785,000,000-3,366,000,0003,227,000,0006,595,000,0007,048,000,0006,492,000,0005,069,000,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Operating a chain of pharmacies throughout Russia, Public Joint-Stock Company Pharmacy Chain 36.6 provides customers with a diverse selection of health and beauty merchandise. The firm engages with its consumer base under the well-known banners of 36.6, Romir, and Gorzdrav. This Moscow-based company was established in 1991.
URL
https://pharmacychain366.ru/
IPO date
Jan 20, 2005
Employees
Domiciled in
RU
Incorporated in
RU

Valuation

Title
RUB in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT